Whittier Trust Co. of Nevada Inc. boosted its position in CME Group Inc. (NASDAQ:CME – Free Report) by 0.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,021 shares of the financial services provider’s stock after purchasing an additional 38 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in CME Group were worth $1,384,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of the company. Vanguard Group Inc. boosted its position in CME Group by 1.2% in the first quarter. Vanguard Group Inc. now owns 34,643,827 shares of the financial services provider’s stock worth $9,190,661,000 after purchasing an additional 400,737 shares during the last quarter. Raymond James Financial Inc. boosted its position in CME Group by 9.7% in the first quarter. Raymond James Financial Inc. now owns 4,113,991 shares of the financial services provider’s stock worth $1,091,401,000 after purchasing an additional 363,130 shares during the last quarter. Vontobel Holding Ltd. boosted its position in CME Group by 3.0% in the second quarter. Vontobel Holding Ltd. now owns 2,920,046 shares of the financial services provider’s stock worth $804,823,000 after purchasing an additional 84,005 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its position in CME Group by 29.9% in the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider’s stock worth $747,744,000 after purchasing an additional 648,591 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in CME Group by 10.3% in the first quarter. AQR Capital Management LLC now owns 2,783,759 shares of the financial services provider’s stock worth $735,539,000 after purchasing an additional 260,065 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Stock Down 0.3%
NASDAQ CME opened at $267.81 on Thursday. The stock’s 50 day moving average is $266.67 and its 200 day moving average is $271.45. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The stock has a market cap of $96.51 billion, a PE ratio of 25.93, a P/E/G ratio of 6.18 and a beta of 0.41.
CME Group Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date of this dividend was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.9%. CME Group’s payout ratio is currently 48.40%.
Insiders Place Their Bets
In other CME Group news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. The trade was a 3.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, General Counsel Jonathan L. Marcus sold 392 shares of CME Group stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 13,043 shares of company stock valued at $3,527,956 in the last 90 days. 0.30% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
A number of research analysts have recently weighed in on CME shares. Keefe, Bruyette & Woods lifted their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a research report on Monday, October 13th. Raymond James Financial lowered their price objective on CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research report on Monday, October 13th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Jefferies Financial Group lowered their price objective on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research report on Thursday, October 9th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus price target of $283.71.
Get Our Latest Analysis on CME Group
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Further Reading
- Five stocks we like better than CME Group
- What is an Earnings Surprise?
- Archer’s Recent String of Victories Signals a New Phase of Growth
- Compound Interest and Why It Matters When Investing
- 3 Key Stocks Boosting Buybacks Amid Improving Fundamentals
- The 3 Best Fintech Stocks to Buy Now
- The Best AI for Picking Stocks, Ranked by Performance
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.